Spinning disc processing technology: Potential for large-scale manufacture of chitosan nanoparticles

Journal of Pharmaceutical Sciences

Volumn 99, Issue 10, 2010, Pages 4326-4336

  Loh, Jing Wen ^a   Schneider, Jessica ^a   Carter, Michelle ^a   Saunders, Martin ^a   Lim, Lee Yong ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Biodegradable polymers; Chitosan; Freeze drying lyophilisation; Large scale manufacture; Light scattering (dynamic); Nanoparticles; Spinning disc processor; Stability

Indexed keywords

ACETYLCYSTEINE; CHITOSAN; NANOPARTICLE; PARACETAMOL; TRIPOLYPHOSPHATE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG RELEASE; LIGHT SCATTERING; NANOTECHNOLOGY; PARTICLE SIZE; RELIABILITY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 77957373814     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22145     Document Type: Article

References (51)

1. van der Lubben IM, Verhoef JC, Borchard G, Junginger HE. 2001. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci 14:201-207. (Pubitemid 32884316)
2. Muzzarelli RAA. 1993. Biochemical significance of exogenous chitins and chitosans in animals and patients. Carbohydr Polym 20:7-16.
3. Illum L. 1998. Chitosan and its use as a pharmaceutical excipient. Pharm Res 15:1326-1331. (Pubitemid 28427917)
4. Muzzarelli RAA. 1996. Human enzymatic activities related to the therapeutic administration of chitin derivatives. Cell Mol Life Sci 53:131-140.
5. Walker J. 1999. Chitosan. North Carolina, US: National Toxicology Program.
6. Qi L, Xu Z, Chen M. 2007. In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles. Eur J Cancer 43:184-193.
7. de Campos AM, Diebold Y, Carvalho ELS, Sánchez A, Alonso MJ. 2004. Chitosan nanoparticles as new ocular drug delivery systems: In vitro stability, in vivo fate, and cellular toxicity. Pharm Res 21:803-810.
8. Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumria R, Bansal K, Dhawan S. 2004. Chitosan microspheres as a potential carrier for drugs. Int J Pharm 274:1-33. (Pubitemid 38457003)
9. Dyer AM, M Hinchcliffe M, Watts P, Castile J, Jabbal-Gill I, Nankervis R, Smith A, Illum L. 2002. Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharm Res 19:998-1008. (Pubitemid 34804242)
10. Durkut S, Elçin YM, Elcin AE. 2006. Biodegradation of chitosan- tripolyphosphate beads: In vitro and in vivo studies. Artif Cells Blood Substit Immobil Biotechnol 34:263-276.
11. Oxley P, Brechtelsbauer C, Ricard F, Lewis N, Ramshaw C. 2000. Evaluation of spinning disk reactor technology for the manufacture of pharmaceuticals. Ind Eng Chem Res 39:2175-2182. (Pubitemid 30460529)
12. Boodhoo KVK, Jachuck RJ. 2000. Process intensification: Spinning disc reactor for condensation polymerisation. Green Chem 2:235-244.
13. Iyer KS, Raston CL, Saunders M. 2007. Hierarchical aqueous self-assembly of C60 nano-whiskers and C60-silver nanohybrids under continuous flow. Lab Chip 7:1121-1124. (Pubitemid 47295978)
14. Bodnar M, Hartmann JF, Borbely J. 2005. Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules 6:2521-2527.
15. Smith N, Raston CL, Saunders M, Woodward R. 2006. Synthesis of Magnetic Nanoparticles Using Spinning Disc Processing. NSTI Nanotechnology Conference and Trade Show - Nanotech 2006 - 9th Annual, Boston.
16. Chin SF, Iyer KS, Saunders M, Raston CL. 2008. Size selective synthesis of superparamagnetic nanoparticles in thin fluids under continuous flowconditions. Adv Funct Mater 18: 922-927. (Pubitemid 351473705)
17. Huang M, Khor E, Lim LY. 2004. Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of molecular weight and degree of deacetylation. Pharm Res 21:344-353. (Pubitemid 38221982)
18. Roberts GAF, Domszy JG. 1982. Determination of the viscometric constants for chitosan. Int J Biol Macromol 4:374-377.
19. Tan SC, Khor E, Tan TK, Wong SM. 1998. The degree of deacetylation of chitosan: Advocating the first derivative UV-spectrophotometry method of determination. Talanta 45:713-719. (Pubitemid 28126509)
20. Block JH, Beale JM, Jr., editors. 2004. Wilson and Gisvold's textbook of organic medicinal and pharmaceutical chemistry, 11th edition. Philadelphia, PA: Lippincott Williams & Wilkins. p 948.
21. Gan Q, Wang T, Cochrane C, McCarron P. 2005. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces 44:65-73. (Pubitemid 41111534)
22. Martien R, Loretz B, Sandbichler AM, Schn̈urch AB. 2008. Thiolated chitosan nanoparticles: Transfection study in the Caco-2 differentiated cell culture. Nanotechnology 19:1-9.
23. Matthews VB, Knight B, Tirnitz-Parker JEE, Boon J, Olynyk JK, Yeoh GCT. 2005. Oncostatin M induces an acute phase response but does not modulate the growth or maturationstatus of liver progenitor (oval) cells in culture. Exp Cell Res 306:252-263.
24. Tirnitz-Parker JEE, Tonkin JN, Knight B, Olynyk JK, Yeoh GCT. 2007. Isolation, culture and immortalisation of hepatic oval cells from adult mice fed a choline-deficient, ethionine-supplemented diet. Int J Biochem Cell Biol 39:2226-2239.
25. Ajun W, Yan S, Li G, Huili L. 2009. Preparation of aspirin and probucol in combination loaded chitosan nanoparticles and in vitro release study. Carbohydr Polym 75:566-574.
26. Wang X, Zheng C, Wu Z, Teng D, Zhang X, Wang Z, Li C. 2009. Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin. J Biomed Mater Res Part B Appl Biomater 88:150-161.
27. Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. 1999. PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug. J Control Release 57:171-185.
28. Lu E, Franzblau S, Onyuksel H, Popescu C. 2009. Preparation of aminoglycoside-loaded chitosan nanoparticles using dextran sulphate as a counterion. J Microencapsul 26:346-354.
29. Hartlieb KJ, Raston CL, Saunders M. 2007. Controlled scalable synthesis of ZnO nanoparticles. Chem Mater 19:5453-5459.
30. Iyer KS, Raston CL. 2007. Fabrication of laterally 'sliced' metal plated carbon nanotubes under aqueous continuous flow conditions. J Mater Chem 17:4872-4875.
31. Iyer KS, Raston CL, Saunders M. 2007. Continuous flow nanotechnology: Manipulating the size, shape, agglomeration, defects and phases of silver nano-particles. Lab Chip 7:1800-1805.
32. Banerjee T, Mitra S, Singh AK, Sharma RK, Maitra A. 2002. Preparation, characterisation and biodistribution of ultrafine chitosan nanoparticles. Int J Pharm 243:93-105.
33. Qi LF, Xu ZR, Li Y, Jiang X, Han XY. 2005. In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells. World J Gastroenterol 11:5136-5141.
34. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. 2004. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 100:5-28.
35. Lim LY, Khor R, Koo O. 1998. Gamma irradiation of chitosan. J Biomed Mater Res 43:282-290.
36. Qi L, Xu Z, Jiang X, Hu C, Zou X. 2004. Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr Res 339:2693-2700.
37. Lim LY, Khor E, Ling C. 1999. Effects of dry heat and saturated steam on the physical properties of Chitosan. J Biomed Mater Res 48:111-116.
38. Leong KW, Mao HQ, Truong-Le VL. 1998. DNA-polycation nanospheres as non-viral gene delivery vehicles. J Control Release 53:183-193.
39. Shu XZ, Zhu KJ. 2001. Chitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelation. J Microencapsul 18:237.
40. Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ. 1997. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 63:125-132.
41. Qi L, Xu Z. 2004. Lead sorption from aqueous solutions on chitosan nanoparticles. Colloids Surf A Physicochem Eng Aspects 251:183-190.
42. Bergera J, Reista M, Mayera JM, Feltb O, Peppasc NA, Gurny R. 2004. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm 57:19-34. (Pubitemid 38058801)
43. Mi FL, Shyu SS, Wong TB, Jang SF, Lee ST, Lu KT. 1999. Chitosan-polyelectrolyte complexation for the preparation of gel beads and controlled release of anticancer drug. II. Effect of pH-dependent ionic crosslinking or interpolymer complex using tripolyphosphate or polyphosphate as reagent. J Appl Polym Sci 74:1093-1107.
44. Lopez-Leon T, Carvalho ELS, Seijo B, Ortega-Vinuesa JL, Bastos-Gonzalez D. 2005. Physicochemical characterization of chitosan nanoparticles: Electrokinetic and stability behavior. J Colloid Interface Sci 283:344-351.
45. Behrens I, Pena AIV, Alonso MJ, Kissel T. 2002. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: The effect of mucus on particle adsorption and transport. Pharm Res 19:1185-1193.
46. Loretz B, Bernkop-Schnurch A. 2007. In vitro cytotoxicty testing of non-thiolated and thiolated chitosan nanoparticles for oral gene delivery. Nanotoxicology 1:139-148.
47. Konan YN, Gurny R, Allemann E. 2002. Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int J Pharm 233:239-252.
48. Gennaro AR, editor. 1990. Remington's pharmaceutical sciences Part 2, 18th edition. Easton, PA: Mack Pub. Co. p 861 & 1109.
49. Liu C-G, Chen X-G, Park H-J. 2005. Self-assembled nanoparticles based on linoleic-acid modified chitosan: Stability and adsorption of trypsin. Carbohydr Polym 62:293-298.
50. Desai KGH, Park HJ. 2005. Preparation and characterisation of drug-loaded chitosan-tripolyphosphate microspheres by spray drying. Drug Dev Res 64:114-128.
51. Takahashi H, Chen R, Okamoto H, Danjo K. 2005. Acetaminophen particle design using chitosan and a spray-drying technique. Chem Pharm Bull 53:37.